Ipsen SA - Company Profile
Powered by
All the data and insights you need on Ipsen SA in one report.
- Save hours of research time and resources with
our up-to-date Ipsen SA Strategy Report
- Understand Ipsen SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Ipsen SA’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Ipsen SA's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Marc de Garidel
Chairman Executive BoardMr. Marc de Garidel has been the Chairman of the company since July 2016. Prior to this, he has been the Chairman and Chief Executive Officer of the company since November 2010. Currently he serves as the Chief Executive Officer and Director of AZTherapies Inc since October 2020; and as Director of Claris Biotherapeutics since July 2020. He has served as the Chief Executive Officer and Director of Corvidia Therapeutics, Inc; Vice-Chairman of the Board of Directors of Vifor Pharma from May 2017, of which he was member of the Board since 2015. He has also worked at Eli Lilly Pharmaceutical Group and Amgen from 1995 to 2010.
David Loew
Chief Executive Officer; Director Executive BoardMr. David Loew has been the Chief Executive Officer of the company since July 2020. Prior to this, he has served as Global Oncology Head, Global Chief Marketing Officer and Head of Global Product Strategy and Region Head, Eastern Europe, Middle East and Africa for the Pharma Division of Roche since 1992; Senior Vice President, Commercial Operations Europe at Sanofi since July 2013; and Chief Executive Officer of Sanofi Pasteur Vaccines in 2016. He currently serves on the Boards of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), and G5 Sante, the federation of French pharmaceutical companies. He has also worked at Coopers & Lybrand and Hewlett Packard in 1990
Aymeric Le Chatelier
Executive Vice President; Chief Financial Officer Senior ManagementMr. Aymeric Le Chatelier has been the Executive Vice President and Chief Financial Officer of the company since November 2014. Prior to this, he has served as Interim Chief Executive Officer of the company since January 2020. Mr. Chatelier has also served as the Group Chief Financial Officer and Deputy Chief Financial Officer of Veolia Water; Group Chief Financial Officer at Arjowiggins; and Director of Financial at Enedis.
Sandra Silvestri, M.D.
Chief Medical Officer; Executive Vice President; Head - Global Medical Affairs, Patient Safety and Patient Affairs Senior ManagementMs. Sandra Silvestri has been the Executive Vice President, Chief Medical Officer and Head of Global Medical Affairs, Patient Safety and Patient Affairs of the company since May 2023. Prior to this, she served as the Senior Vice President and Chief Medical Officer of the General Medicines Global Business Unit. Previously, she served as the Global Head of Medical Affairs Capabilities Centre of Excellence and Medical Hub. she also held numerous national and international roles at Eli Lilly across R&D and Scientific Communications.
Francois Garnier
Chief Business Ethics Officer; Executive Vice President; General Counsel Senior ManagementMr. Francois Garnier has been the Chief Business Ethics Officer, Executive Vice President, and General Counsel since December 2014. Prior to this, he has been the Chief Counsel for Pfizer Inc. from January 2014; Chief Counsel for Pfizer’s operations in Europe from 2009 to 2014; and Vice-President, General Counsel in 2003. He has also been the Associate Counsel, Chief Counsel for France and Chief Counsel at Aventis Animal Nutrition until 2001; and Chief Counsel for Europe for Pharmacia Group. Mr. Francois Garnier has also been the Counsel for Corporate Transactions for Rhone Poulenc Rorer SA; International Contracts Manager at Servier SA from 1989 until September 1995.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer